Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000867812 | SCV000533452 | likely benign | not provided | 2020-09-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000867812 | SCV001009076 | likely benign | not provided | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399823 | SCV002710737 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500779 | SCV002802143 | likely benign | Arrhythmogenic right ventricular dysplasia 1; Rienhoff syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937899 | SCV004765034 | likely benign | TGFB3-related disorder | 2022-11-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |